News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
kally wong
#NewMember | "AseBio allows to know the latest market trends and connect with the Spanish biotech industry"
Healthcare
Meet our new memeber DSM Pentapharm. We talk with Kally Wong,  con la …
CENER
More than 160 spanish biotech companies seek out solutions for a greener industry
Industrial biotechnology · BioSpain
Most of these companies will be at the most important annual event for the sector, BIOSPAIN 2021,…
foto oryzon
ORYZON announces FDA approval of IND for PORTICO, a Phase IIb trial with vafidemstat in Borderline Personality Disorder
Healthcare
Recruitment ongoing in Europe. Primary objectives: to assess the effect of vafidemstat to…
Partners - Oryzon Genomics
foto oryzon 2
ORYZON presents iadademstat ALICE 30-month data at EHA-2021, confirming positive and robust efficacy in combination with azacitidine in AML
Healthcare
Robust signals of clinical efficacy, with ORR of 83%, of which 67% are CR/CRi and five…
Partners - Oryzon Genomics
biodesayuno foto
BIOSPAIN represents a boost for investment in a decisive year for biotechnology
BioSpain · Financing · Communication
The pandemic has provided an opportunity for Spanish biotechnology and private investment has…
genesis biomed
Algorithms and Image Biomarkers. Radiomics as another piece of precision oncology
Personalized medicine
Radiomics is revolutionising medical image interpretation
Partners - GENESIS Biomed
lim global
LIM Global, Digital transformation and rebranding by eMascaró
The objectives were clear: communicate the brand's values, encourage customer attraction, entice…
Partners - LIM Global
owl
OWL Metabolomics and Sagimet Biosciences closed an agreement to use OWL´s services in Sagimet´s Phase 2b FASCINATE-2 Clinical Trial
Healthcare
In a recent Phase 2a trial, TVB-2640 improved serum biomarkers of liver injury in patients with…
Ysios Capital anuncia la salida a bolsa en el NASDAQ de su compañía participada CVRx, Inc.
Ysios Capital closes its third fund at €216 million ($260 million)
Ysios BioFund 3 (YBF 3) is the firm’s largest fund to date. To invest in up to 15 companies in…
Partners - Ysios Capital Partners